Arcturus Therapeutics Ltd (ARCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ARCT | AMGN | VRTX | BMY | GILD |
| Company | Arcturus Therapeutics Ltd | Amgen Inc | Vertex Pharmaceutic | Bristol-Myers Squibb Company | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NYSE | NASDAQ |
| Open | 16.08 | 279.38 | 465.19 | 56.18 | 88.39 |
| High | 17.37 | 281.36 | 467.74 | 56.81 | 89.04 |
| Low | 15.71 | 276.56 | 458.05 | 55.84 | 87.63 |
| Last | 17.08 | 279.05 | 466.27 | 56.58 | 88.37 |
| Change | +1.06 | -2.31 | +0.57 | +0.36 | -0.03 |
| % Change | +6.62% | -0.82% | +0.12% | +0.64% | -0.03% |
| Volume | 508,243 | 1,430,712 | 397,309 | 4,509,072 | 3,660,502 |
| 20-Day Average Volume | 404,214 | 2,500,996 | 1,180,853 | 11,478,095 | 7,279,849 |
| Previous Close | 16.02 | 281.36 | 465.70 | 56.22 | 88.40 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 18.70 | 312.04 | 482.55 | 55.14 | 90.78 |
| 20-Day Raw Stochastic | 32.11% | 4.04% | 12.79% | 52.27% | 20.53% |
| 20-Day Relative Strength | 39.90% | 26.78% | 44.85% | 57.58% | 50.32% |
| Weighted Alpha | -45.34 | -3.51 | +23.79 | +21.39 | +23.30 |
| Today's Opinion | 100% Sell | 40% Sell | 16% Buy | 100% Buy | 80% Buy |
| Previous Opinion | 100% Sell | 40% Sell | 16% Buy | 100% Buy | 80% Buy |
| Last Month's Opinion | 64% Sell | 24% Buy | 56% Buy | 88% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -16.18% since 11/11/24 | -13.41% since 11/11/24 | -7.13% since 11/11/24 | -5.29% since 11/11/24 | -8.97% since 11/11/24 |
| Low | 14.93 on 11/15/24 | 276.56 on 11/18/24 | 458.05 on 11/18/24 | 55.82 on 11/15/24 | 87.63 on 11/18/24 |
| High | 20.07 on 11/12/24 | 321.22 on 11/12/24 | 508.04 on 11/12/24 | 60.62 on 11/12/24 | 96.84 on 11/12/24 |
| 1-Month | |||||
| %Chg | -19.27% since 10/18/24 | -13.37% since 10/18/24 | -3.53% since 10/18/24 | +6.45% since 10/18/24 | +1.86% since 10/18/24 |
| Low | 14.93 on 11/15/24 | 276.56 on 11/18/24 | 458.05 on 11/18/24 | 51.81 on 10/28/24 | 85.60 on 10/22/24 |
| High | 21.61 on 11/11/24 | 328.25 on 11/08/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| 3-Month | |||||
| %Chg | -15.47% since 08/16/24 | -13.31% since 08/16/24 | -2.39% since 08/16/24 | +14.78% since 08/16/24 | +19.72% since 08/16/24 |
| Low | 14.93 on 11/15/24 | 276.56 on 11/18/24 | 447.70 on 10/07/24 | 46.88 on 08/22/24 | 73.27 on 08/19/24 |
| High | 25.88 on 10/02/24 | 339.17 on 09/23/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| 6-Month | |||||
| %Chg | -42.66% since 05/17/24 | -10.82% since 05/17/24 | +4.66% since 05/17/24 | +28.67% since 05/17/24 | +30.43% since 05/17/24 |
| Low | 14.93 on 11/15/24 | 276.56 on 11/18/24 | 435.57 on 05/30/24 | 39.35 on 07/05/24 | 62.07 on 05/31/24 |
| High | 45.00 on 06/05/24 | 346.85 on 07/25/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 433,934 | 152,449,728 | 119,931,248 | 114,024,112 | 110,169,920 |
| Shares Outstanding, K | 27,087 | 537,533 | 257,529 | 2,028,177 | 1,246,266 |
| Annual Sales | 166,800,000 | 28,190,000,000 | 9,869,200,000 | 45,006,000,000 | 27,116,000,000 |
| Annual Net Income | -29,730,000 | 6,717,000,000 | 3,619,600,000 | 8,025,000,000 | 5,665,000,000 |
| Last Quarter Sales | 41,670,000 | 8,503,000,000 | 2,771,900,000 | 11,892,000,000 | 7,545,000,000 |
| Last Quarter Net Income | -6,900,000 | 2,830,000,000 | 1,045,400,000 | 1,211,000,000 | 1,253,000,000 |
| 60-Month Beta | 2.64 | 0.60 | 0.39 | 0.44 | 0.17 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.26 on 11/07/24 | 5.58 on 10/30/24 | 4.38 on 11/04/24 | 1.80 on 10/31/24 | 2.02 on 11/06/24 |
| Latest Earnings Date | 11/07/24 | 10/30/24 | 11/04/24 | 10/31/24 | 11/06/24 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | N/A | 0.600 on 10/04/24 | 0.770 on 09/13/24 |
| Next Ex-Dividends Date | 01/04/13 | 11/18/24 | N/A | 10/04/24 | 12/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 15.40 | 0.00 | 50.00 | 20.79 |